MTARC2 and hepatocellular carcinoma: It was recently found that MTARC2 expression might be a favourable indicator in the progression of HCC (196, 197) and the likely mechanism of this effect is particularly interesting: Wu et al. (196) propose that mARC2 competes with the tumour suppressor protein p27 for the same degradation pathway.